Status
Conditions
Treatments
About
adherence of digital follow-up in a population of elderly patients.
Full description
The use of digital self-questionnaires adapted to elderly patients but also to BrC and Bac could detect the toxicities of chemotherapy and we formulate the hypothesis that the continuous monitoring of these different variables in elderly patients treated with chemotherapy is possible and acceptable to this population.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Age ≥ 70 years,
Patient with an indication of adjuvant chemotherapy showing:
WHO ≤ 3 (WHO index - World Health Organization) 5. Estimated life expectancy> 6 months 6. patients with a smartphone or tablet with an internet connection. It can also be offered to patients whose primary caregiver or the person of trust (including the partner) has a smartphone, an internet connection or a tablet provided that he or she is present more than three times during the week. during chemotherapy to ensure smooth weekly data transfer and filling of questionnaires 7. Signed consent to participation 8. Affiliation to, or beneficiary of, a social security scheme
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
119 participants in 1 patient group
Loading...
Central trial contact
Dominique GENRE, MD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal